(S)-(+)-2,2-Dimethylcyclopropanecarboxamide CAS 75885-58-4 Purity >98.0% (GC) Cilastatin Sodium Intermediate

Short Description:

(S)-(+)-2,2-Dimethylcyclopropanecarboxamide 

CAS: 75885-58-4

Purity: >98.0% (GC)

Appearance: White or Off-White Crystalline Powder

Intermediate of Cilastatin Sodium (CAS: 81129-83-1)

Contact: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

75885-58-4 - Description:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of (S)-(+)-2,2-Dimethylcyclopropanecarboxamide (CAS: 75885-58-4) with high quality, intermediate of Cilastatin Sodium (CAS: 81129-83-1). Formulations containing Cilastatin in combination with Imipenem have been used to treat susceptible bacterial infections.
Ruifu Chemical has been supplying pharmaceutical intermediates and APIs, fine chemicals more than 15 years.
Ruifu Chemical can provide worldwide delivery, competitive price, excellent service.
Purchase Cilastatin Sodium intermediates, please contact us by e-mail: alvin@ruifuchem.com

Intermediates of Cilastatin Sodium:

75885-58-4 - Chemical Properties:

Chemical Name (S)-(+)-2,2-Dimethylcyclopropanecarboxamide 
Synonyms SDMCA; (S)-(+)-DMCPA; S-(+)-2,2-Dimethylcyclopropane Carboxamide; (S)-2,2-Dimethylcyclopropane-1-Carboxamide
Stock Status In Stock, Commercial Production  
CAS Number 75885-58-4
Molecular Formula C6H11NO
Molecular Weight 113.16 g/mol
Melting Point 135.0 to 140.0℃ 
Density 1g/cm3
Solubility  Soluble in Methanol
Storage Temperature Store Long-Term in a Cool and Dry Place 
COA & MSDS Available
Origin of Product    Shanghai, China
Product Categories
Pharmaceutical Intermediates; Chiral Building Blocks
Brand Ruifu Chemical

75885-58-4 - Specifications:

Items Specifications  Results
Appearance White or Off-White Crystalline Powder  Conforms  
Melting Point 135.0~140.0℃ 135.0~137.0℃
Specific Rotation [a]20/D +78.0° to +88.0° (C=1 in Methanol) +82.3°
Water by Karl Fischer  <0.50% 0.25%
Sulphate Ash  <0.20% 0.08%
Purity / Analysis Method >99.0% (GC)  99.9%
Chiral Purity (e.e.) >99.0% (GC)  99.8%
1H NMR Spectrum Conforms to Structure   Conforms   
Conclusion The product has been tested and complies with the given specifications
Application Intermediate of Cilastatin Sodium (CAS: 81129-83-1)

75885-58-4 - Package/Storage/Shipping:

Package: Fluorinated bottle, Aluminium foil bag, 25kg/cardboard drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry and well-ventilated warehouse away from incompatible substances. Keep away from sunshine; avoid fire and heat sources; avoid moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery. 

75885-58-4 - Advantages:

Sufficient Capacity: Sufficient facilities and technicians

Professional Service: One stop purchasing service

OEM Package: Custom package and label available

Fast Delivery: If within stock, three days delivery guaranteed

Stable Supply: Maintain reasonable stock    

Technical Support: Technology solution available

Custom Synthesis Service: Ranged from grams to kilos

High Quality: Established a complete quality assurance system

75885-58-4 - FAQ:

How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com 

15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.

Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.

Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.

Quality AssuranceStrict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.

SamplesMost products provide free samples for quality evaluation, shipping cost should be paid by customers.

Factory AuditFactory audit welcome. Please make an appointment in advance.

MOQ? No MOQ. Small order is acceptable.

Delivery Time? If within stock, three days delivery guaranteed.

TransportationBy Express (FedEx, DHL), by Air, by Sea.

Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.

Custom SynthesisCan provide custom synthesis services to best fit your research needs.

Payment TermsProforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc. 

75885-58-4 - Risk and Safety:

Risk Codes
R22 - Harmful if swallowed
R36/37/38 - Irritating to eyes, respiratory system and skin.
Safety Description
S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36 - Wear suitable protective clothing.
WGK Germany 3
HS Code 2924 2990.99
Hazard Note Irritant 

75885-58-4 - Application:

(S)-(+)-2,2-Dimethylcyclopropanecarboxamide (CAS: 75885-58-4), intermediate of Cilastatin (CAS: 82009-34-5) and Cilastatin Sodium (CAS: 81129-83-1).
Cilastatin has antibacterial effects on Gram-positive and negative aerobic and anaerobes. The antibacterial spectrum includes Streptococcus, Staphylococcus aureus, Escherichia coli, Klebsiella, some strains of Acinetobacter, Haemophilus bacillus, Proteus, Serratia, Pseudomonas aeruginosa, etc. Clinically, Cilastatin is mainly used for respiratory tract infections, biliary tract infections, urinary system and abdominal cavity infections, skin and soft tissues, bones and joints, gynecological infections caused by gram-positive bacteria, negative bacteria, and anaerobic bacteria.
Cilastatin was designed to inhibit renal metabolism of Imipenem and prolong its half-life. Formulations containing Cilastatin in combination with Imipenem have been used to treat susceptible bacterial infections.
When administered alone, Imipenem is metabolised in the kidneys by dehydropeptidase-I, an enzyme in the brush border of the renal tubules, to inactive, nephrotoxic metabolites, with only about 5 to 40 or 45% of a dose excreted in the urine as unchanged active drug. Cilastin inhibits the metabolism of imipenem. When given with cilastatin about 70% of an intravenous dose of Imipenem is recovered unchanged in the urine within 10 hours. Cilastatin is also excreted mainly in the urine, the majority as unchanged drug and about 12% as N-Acetyl Cilastatin. Less than 1% of Imipenem is excreted via the bile in the faeces. 

  • Write your message here and send it to us